ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,144.15
0.24%
Dow Jones
44,627.59
0.16%
US Dollar vs MXN
20.45277
0.99%
Brent Oil
75.845
0.47%
Bitcoin
96,386.25
0.86%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE

  6. Celadon Pharmaceuticals Plc (CEL) Cotización

Celadon Pharmaceuticals Plc

Celadon Pharmaceuticals Plc (CEL)

Challenger Gold Limited
17.50
1.00
(6.06%)
Cerrado 19 Febrero 10:30AM
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
17.50
Postura de Compra
16.00
Postura de Venta
19.00
Volume Operado de la Acción
423,088
16.50 Rango del Día 17.50
12.50 Rango de 52 semanas 120.00
Capitalización de Mercado [m]
11.589M
Precio Anterior
16.50
Precio de Apertura
16.50
Hora
1237
@
16.18
(O)
Última hora de negociación
Volumen financiero
76,579p
Precio Promedio Ponderado
18.10
Volumen promedio (3 m)
170,626
Acciones en circulación
66,220,807
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-1.62
Beneficio por acción (BPA)
-0.11
turnover
149k
Beneficio neto
-7.14M

Acerca de Celadon Pharmaceuticals Plc

Sector
Pharmaceutical Preparations
Industria
Investment Advice
Sitio web
celadonpharma.co.uk
Sede
London, Gbr
Fundado
2022
Celadon Pharmaceuticals Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker CEL. The last closing price for Celadon Pharmaceuticals was 16.50p. Over the last year, Celadon Pharmaceuticals shares have traded in a share price range of 12.50p to 120.00p.

Celadon Pharmaceuticals currently has 66,220,807 shares in issue. The market capitalisation of Celadon Pharmaceuticals is £10.93 million. Celadon Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.62.

CEL Últimas noticias

Más noticias
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-3.5-16.66666666672121.515.2256962818.56688114DE
4-4-18.604651162821.524.513.516186919.29618524DE
1254012.542.512.517062623.62017939DE
26-10-36.363636363627.558.512.514883627.56750092DE
52-95-84.4444444444112.512012.510437840.31288437DE
156-132.5-88.333333333315018512.56498467.93220768DE
260-80-82.051282051397.533012.54489393.0466969DE

CEL - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Celadon Pharmaceuticals?
El precio actual de las acciones de Celadon Pharmaceuticals es 17.50p
¿Cuántas acciones de Celadon Pharmaceuticals están en circulación?
Celadon Pharmaceuticals tiene 66,220,807 acciones en circulación
¿Cuál es la capitalización de mercado de Celadon Pharmaceuticals?
La capitalización de mercado de Celadon Pharmaceuticals es GBP 10.93M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Celadon Pharmaceuticals?
Celadon Pharmaceuticals ha negociado en un rango de 12.50p a 120.00p durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Celadon Pharmaceuticals?
El ratio precio/beneficio de Celadon Pharmaceuticals es -1.62
¿Cuál es el ratio de efectivo a ventas de Celadon Pharmaceuticals?
El ratio de efectivo a ventas de Celadon Pharmaceuticals es 76.09
¿Cuál es la moneda de reporte de Celadon Pharmaceuticals?
Celadon Pharmaceuticals presenta sus resultados financieros en GBP
¿Cuál es el último ingresos anual de Celadon Pharmaceuticals?
El último ingresos anual de Celadon Pharmaceuticals es GBP 149k
¿Cuál es el último beneficio anual de Celadon Pharmaceuticals?
El último beneficio anual de Celadon Pharmaceuticals es GBP -7.14M
¿Cuál es la dirección registrada de Celadon Pharmaceuticals?
La dirección registrada de Celadon Pharmaceuticals es 32-33 COWCROSS STREET, LONDON, EC1M 6DF
¿Cuál es la dirección del sitio web de Celadon Pharmaceuticals?
La dirección del sitio web de Celadon Pharmaceuticals es celadonpharma.co.uk
¿En qué sector industrial opera Celadon Pharmaceuticals?
Celadon Pharmaceuticals opera en el sector INVESTMENT ADVICE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ARKArkle Resources Plc
0.30p
(50.00%)
19.52M
GALGalantas Gold Corporation
3.50p
(34.62%)
523.4k
CGNRConroy Gold & Natural Resources Plc
3.95p
(33.90%)
7.68M
DEMGDeltex Medical Group Plc
0.035p
(27.27%)
6.07M
PETPetrel Resources Plc
1.50p
(25.00%)
838.99k
TCFTheracryf Plc
0.275p
(-72.50%)
28.23M
IHCInspiration Healthcare Group Plc
18.50p
(-25.40%)
2.73M
SYMESupply@me Capital Plc
0.0035p
(-22.22%)
1.35B
ZYTZytronic Plc
41.50p
(-20.95%)
292.91k
ROSERosebank Industries Plc
630.00p
(-17.11%)
4.44k
SYMESupply@me Capital Plc
0.0035p
(-22.22%)
1.35B
NTVONativo Resources Plc
0.0015p
(0.00%)
1.23B
PREMPremier African Minerals Limited
0.018p
(-10.00%)
691.92M
VASTVast Resources Plc
0.1625p
(16.07%)
182.84M
SNDASunda Energy Plc
0.0625p
(-0.48%)
181.37M

Discusión

Ver feed completo
Ozie2bobthericher Ozie2bobthericher 3 minutos hace
Yes you read correctly 0.0025 I got 1500 shares for approximately $25 including fees 😂 .
CDBT
TenKay TenKay 4 minutos hace
“However, my desire for a price of 0.0002 does not indicate a preference for that specific value over any upward trend in the stock price.“

Well that’s a pretty confusing and mildly contradictory statement. 🤣
HMBL
poguemahone poguemahone 4 minutos hace
Mike:

I’m giving them 2 more years—if we’re still stuck in this eddy of despair then I’ll dust myself off and move on.

Watching paint dry and grass grow is more exciting than watching this SP action (or lack thereof). The JPM conference (along with Missling’s horrible
JPM
cottonisking cottonisking 4 minutos hace
🐢🐢🐢 2
the United States Attorney for the Southern District of New York; (v) all parties who have
requested notice in these chapter 11 cases; and (vi) the Plan Trustees, and it appearing that no
other or further notice need be provided; and a hearing ha
LEHNQ
TooFrank TooFrank 4 minutos hace
I came across prices of a battery swap unit costing $500,000 to a low of 1/3 of the $500k price… and every thing in between.
That really is a good question. I will dig a little deeper and let you know.
NIO
meirluc meirluc 5 minutos hace
Excellent analysis Tunnel. However, if the 3 posters on this MB
were right and the last inspection was only completed at the very
end of January, wouldn't our MAA application have its second CHM review
no earlier than February 27-28 and if so, we may receive the approval
NWBO
Participation_trophy_inc Participation_trophy_inc 5 minutos hace
Yeah go PGG !!!! Add the $10.5 million to the $12.5 billion and a dash of $22 trillion and my hero Henry Fahman is cooking !!!! Go Henry you can do it haha
PHIL
boi568 boi568 6 minutos hace
What an ironic response from someone relying on his opinion to someone who is relying on stats.
AVXL
northam43 northam43 6 minutos hace
Report #9 SPX Record of All Time Highs

https://investorshub.advfn.com/uimage/uploads/2025/2/19/cacnj9_ATH_Report.PNG
Jack_Bolander Jack_Bolander 6 minutos hace
HYDROGEN Hasn't had a Week this BAD Since : May 6, 1937 !

https://www.youtube.com/watch?v=sa9SQh_OIj0
PLUG
TenKay TenKay 6 minutos hace
Just as long as there is bacon wrapped shrimp!!!
HMBL
ergo sum ergo sum 6 minutos hace
Seat belts
Lone Clone Lone Clone 6 minutos hace
ETRUSCUS RELEASES IP RESULTS, DOUBLING SIZE OF SIGNIFICANT PORPHYRY TARGET AT ZAPPA

https://www.prnewswire.com/news-releases/etruscus-releases-ip-results-doubling-size-of-significant-porphyry-target-at-zappa-302380218.html

News provided by Etruscus Resources Corp. Feb 1
SKE
getmoreshares getmoreshares 6 minutos hace
BHAT is looking REAL GOOD-- $$$$$
BHAT
Stock_Barber Stock_Barber 7 minutos hace
Says the fully discredited and uncredentialed author of the company's Shareholder Updates...

💩
DBMM
glenn1919 glenn1919 7 minutos hace
MULN............................................................................................slapthatr/slow...............................A/H
MULN
dinogreeves dinogreeves 8 minutos hace
Yeah, read those a few days ago, this dump was pre planned. Either way, it is stair stepping nicely.
SMCI
getmoreshares getmoreshares 8 minutos hace
looking good AH!!!!!!!!!!!!!
BHAT
Techroemancer Techroemancer 8 minutos hace
I think in 3 years time, the company can easily uplist into NYSE if enough momentum is gained. Below are the requirements. 3 years out either way if progress continues in a way that management is hoping. This is a solid investment given everything IMO

• EARNINGS TEST: Adjusted pre -ta
ASII
louieforpar louieforpar 8 minutos hace
How many now since the culling of FAA employees? Is there a direct link to this administration or just that 1-in-a-billion coincidence?


LVerstee LVerstee 8 minutos hace
They did complete KYC. They are simply waiting for clearance now from the bank's compliance team. They were expecting it on friday as there are no open issues, but they haven't received it yet.

There are no twists and turns.

They completed KYC you said. Which one is it.
ITUP
Hercules1 Hercules1 8 minutos hace
Well idea it to make a few bucks.

Nobody hangs around too long in this stock game.

But with that being said, stock has been strong.

It can possibly break .10 tomorrow.


So that is why I bought the dip and then added a few more.
BHAT
Poo28 Poo28 9 minutos hace
Shareholders know the Nevers have no credentials nor do they have expertise except their opinions which have never been valid.

Just like the OIP, extracting, often out of context, and from Google no less is not due diligence , and why Never right. That is why there are credentialed ex
DBMM
Hi_Lo Hi_Lo 9 minutos hace
It is amazing how stupid him and his lawyer are. They are the ones suing and then just abandon the requirements for a lawsuit?
It's all empty scare tactics since he thinks everyone will cave to him before the lawsuit begins.

What has been proven is that he's a paper tiger with
SONG
KngmAz KngmAz 9 minutos hace
Very positive update HGRAF video by the C.E.O. came out today. Hope that everyone saw it. Huge.
HGRAF

Su Consulta Reciente

LSE
CEL
Celadon Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios